Models of autoimmune demyelination in the central nervous system: on the way to translational medicine
Year: 2009
Type: article
Abstract: Multiple sclerosis (MS) is the most common neurologic disease of young adults. In the recent years, our understanding on disease pathomechanisms has considerably improved and new therapies have emerged. Yet a cure for this devastating disorder is still a far cry away and human resources on ex vivo specimens are limited. More than 70 years after its first description, experimental autoimmune encephalomyelitis (EAE) remains an important tool to understand concepts of T cell mediated autoimmunity as well as the roles of the innate and the humoral immune systems. Some EAE models also well reflect mechanisms of tissue damage including demyelination, axonal injury and also cortical changes. A limitation of the classical EAE model is a neglect of CD8 T cell mediated immune mechanisms. Moreover, well characterized models for primary progressive MS or demyelination patterns involving primary oligodendrocyte dystrophy are still not available. Yet many current therapeutic concepts including glatiramer acetate or natalizumab stem from their successful first application in EAE models. New strategies include the widespread use of conditional knockout mice to understand the cell-type specific function of single genes, innovative approaches to establish models on the roles of B cells and CD8 T cells as well as on the relation of inflammation to primary degeneration. In summary, EAE models continue to play an important role in neuroimmunology thereby also stimulating research in other fields of the neurosciences and immunobiology.
Authors: Ralf A Linker, De-Hyung Lee
Institutions: St. Josef-Hospital, Ruhr University Bochum
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: multiple sclerosis, experimental autoimmune encephalomyelitis, autoimmune demyelination, animal models of multiple sclerosis, T cell-mediated autoimmunity, CD8+ T cells, primary progressive multiple sclerosis, axonal injury, cortical changes, B cells, conditional knockout mice, neuroimmunology, glatiramer acetate, natalizumab, translational medicine
Open Access status: hybrid
OpenAlex ID: W1997209939
